Cargando…

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma

In this Perspective, Neehar Parikh and Amit Singal discuss the advantages of the ITA.LI.CA staging system for prognoses of liver cancer developed by Alessandro Vitale and colleagues.

Detalles Bibliográficos
Autores principales:	Parikh, Neehar D., Singal, Amit G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846025/ https://www.ncbi.nlm.nih.gov/pubmed/27116028 http://dx.doi.org/10.1371/journal.pmed.1002005

Ejemplares similares

Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications
por: Vitale, Alessandro, et al.
Publicado: (2021)

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice
por: Giannini, Edoardo G., et al.
Publicado: (2019)

Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Kassab, Ihab, et al.
Publicado: (2023)

Is hepatocellular carcinoma surveillance in high-risk populations effective?
por: Onyirioha, Kristeen, et al.
Publicado: (2020)

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic
por: Mehta, Neil, et al.
Publicado: (2021)

Ita Andehui : leyenda mixteca /
por: Martínez Gracida, Manuel, 1847-1924
Publicado: (2014)

Bhagavad-g{macr}ita as it is /
Publicado: (1984)

A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022)

A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation
por: Wang, Mengjun, et al.
Publicado: (2022)

Systemic treatment for hepatocellular carcinoma
por: Aggarwal, Manushi, et al.
Publicado: (2018)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
por: Marquardt, Patrick, et al.
Publicado: (2021)

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Parikh, Neehar D., et al.
Publicado: (2018)

SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma
por: Shen, Qingyu, et al.
Publicado: (2018)

Comparison of Staging Systems of Hepatocellular Carcinoma
por: Sirivatanauksorn, Yongyut, et al.
Publicado: (2011)

Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies
por: Liang, Jing, et al.
Publicado: (2019)

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort
por: Parikh, Neehar D., et al.
Publicado: (2022)

The prevalence of insomnia in different COVID-19 policy phases: Longitudinal evidence from ITA.LI – Italian Lives
por: Riva, Egidio, et al.
Publicado: (2022)

Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis
por: Singal, Amit G., et al.
Publicado: (2022)

ITAS: Integrated Transcript Annotation for Small RNA
por: Stupnikov, Alexey, et al.
Publicado: (2022)

Body Composition Features Predict Overall Survival in Patients With Hepatocellular Carcinoma
por: Singal, Amit G, et al.
Publicado: (2016)

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
por: Brown, Andrew M., et al.
Publicado: (2022)

Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Validation and ranking of seven staging systems of hepatocellular carcinoma
por: Chen, Zhan-Hong, et al.
Publicado: (2017)

Evolution of systemic therapy for advanced-stage hepatocellular carcinoma
por: Hur, Moon Haeng, et al.
Publicado: (2022)

Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging
por: Yokoo, Takeshi, et al.
Publicado: (2017)

Differential effects of COVID-19 and containment measures on mental health: Evidence from ITA.LI—Italian Lives, the Italian household panel
por: Lucchini, Mario, et al.
Publicado: (2021)

Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy
por: Bonafede, Machaon M., et al.
Publicado: (2019)

PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
por: Gutierrez Reyes, Cristian D., et al.
Publicado: (2021)

Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method
por: Lin, Yu, et al.
Publicado: (2022)

Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma
por: Cheng, Chih H, et al.
Publicado: (2011)

Substrate specificities of Escherichia coli ItaT that acetylates aminoacyl-tRNAs
por: Zhang, Chuqiao, et al.
Publicado: (2020)

Marketing and Distribution System Foster Misuse of Antibiotics in the Community: Insights from Drugs Wholesalers in India
por: Kotwani, Anita, et al.
Publicado: (2022)

Cost analysis of adjuvant management strategies in early stage (stage I) testicular seminoma
por: Cox, John A, et al.
Publicado: (2015)

Perspective: The Mechanobiology of Hepatocellular Carcinoma
por: Loneker, Abigail E., et al.
Publicado: (2021)

Mitochondria take center stage
por: Sheu, Shey-Shing, et al.
Publicado: (2012)

Polarity sets the stage for cytokinesis
por: Hehnly, Heidi, et al.
Publicado: (2012)

New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2022)

A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC
por: Cabrera, Roniel, et al.
Publicado: (2020)

Variation in Glucosinolate Accumulation among Different Sprout and Seedling Stages of Broccoli (Brassica oleracea var. italica)
por: Lin, Haiyan, et al.
Publicado: (2022)

Intelligent Therapy Assistant (ITA) for cognitive rehabilitation in patients with acquired brain injury
por: Solana, Javier, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0v9t0gcq4qqb6c3fn5cocdol80